glp-1 agonists reduce inflammation Weight Reduction with and Paths for Discontinuation While Maintaining Weight Loss Why are GLP-1 agonists being
Description
Only when Eli Lilly began testing dual GLP-1/GIP agonists did the picture change dramatically
3 While effective, this method can be inconvenient for many patients and may result in lower adherence compared to oral medications
So please dont nail us to the wall on this oneits necessary for clarity
The first precursor to Ozempic and Mounjaro came out 20 years ago
Theres no getting around it: GLP-1 medications arent cheap
Medication Interactions: If you are already taking insulin or other diabetes medications, the risk of hypoglycemia (low blood sugar) increases
